Reviewing the Impact of Machine Learning on Disease Diagnosis and Prognosis: A Comprehensive Analysis

Artificial Intelligence (AI) is revolutionizing the healthcare sector by offering innovative solutions to various challenges. This review explores the applications and benefits of AI in healthcare including AI techniques, machine learning, natural language processing, and computer vision, which are being utilized to enhance medical diagnostics, treatment planning, patient care, and administrative processes. One significant application of AI in healthcare is medical imaging analysis. Machine learning algorithms can analyze medical images such as X-rays, MRIs, and CT scans with high accuracy, aiding in early detection and diagnosis of diseases like cancer and neurological disorders. Additionally, AI-powered predictive analytics enable healthcare providers to forecast patient outcomes and identify individuals at risk of developing certain conditions, allowing for proactive intervention and personalized treatment plans. Furthermore, AI-driven virtual health assistants and chabot’s provide patients with instant access to medical information, advice, and support, improving healthcare accessibility and patient engagement. Natural language processing algorithms enable these systems to understand and respond to patients' queries and concerns effectively. In clinical decision support systems, AI algorithms analyze vast amounts of patient data, including medical records, genetic information, and real-time physiological data, to assist healthcare professionals in making informed decisions about diagnosis and treatment strategies. Moreover, AI-driven robotic surgery systems enhance surgical precision, reduce errors, and shorten recovery times. Despite the numerous benefits, challenges such as data privacy concerns, regulatory compliance, and the need for interdisciplinary collaboration remain. However, with ongoing advancements in AI technology and increased adoption by healthcare organizations, the potential for AI to transform healthcare delivery, improve patient outcomes, and reduce costs is substantial. Collaborative efforts between AI developers, healthcare providers, policymakers, and regulators are essential to harnessing the full potential of AI in healthcare while ensuring ethical and responsible use.

Artificial intelligence (AI) has the potential to completely change how healthcare is delivered, revolutionizing the healthcare sector. Precision diagnosis, proactive disease prevention, personalised treatment plans, real-time monitoring and intervention, improved medical imaging, streamlined healthcare workflows, ethical considerations, and the potential future implications of AI in healthcare are all explored in this paper. The first section describes how precision diagnosis using AI technologies is improving diagnostic accuracy. Personalised treatment regimens and earlier disease detection are made possible by machine learning algorithms' analysis of enormous volumes of patient data. Additionally, AI makes it possible to actively prevent disease by using predictive analytics to identify those who are most likely to develop a particular condition, enabling early intervention and tailored preventive actions. The second segment focuses on how AI is transforming therapeutic approaches. AI algorithms create individualised treatment regimens by analyzing patient data, including genetics, biomarkers, and information on therapy response. This maximizes treatment efficacy and minimizes side effects. Additionally, wearable technology and remote monitoring devices powered by AI allow for real-time monitoring and intervention, improving patient safety and lowering hospital readmissions. Examines how AI has affected medical imaging. Radiologists' efficiency and accuracy in identifying anomalies are increased by deep learning algorithms' analysis of complicated medical pictures like CT scans and MRIs. As a result, diagnoses are made more quickly and accurately, allowing for quicker interventions and better patient outcomes. The fourth chapter examines how AI streamlines medical procedures. Administrative responsibilities are reduced and errors are minimized by automating operations like appointment scheduling and documentation. By offering timely support and triaging symptoms, intelligent catboats and virtual assistants increase patient involvement and happiness. The fifth segment talks with ethical issues related to AI in healthcare. In order to create and use AI algorithms responsibly, patient privacy, data security, and bias mitigation are essential. Fair and equitable healthcare practices must be ensured by ethical standards and legal requirements. The abstract wraps off with a preview of the potential effects of AI on healthcare delivery in the future. Emerging medical technologies including telemedicine, robotics, predictive analytics, and AI-assisted surgery show immense promise for revolutionizing the industry. To overcome obstacles, maximize advantages, and guarantee a human-centric approach in the integration of AI in healthcare, cooperation between healthcare practitioners, technologists, policymakers, and ethicists is essential.

Nutrient solution plays an essential role in providing macronutrients to hydroponic plants. Determining nitrogen in the form of nitrate is crucial, as either a deficient or excessive supply of nitrate ions may reduce the plant yield or lead to environmental pollution. This work aims to evaluate the performance of feature reduction techniques and conventional machine learning (ML) algorithms in determining nitrate concentration levels. Two features reduction techniques, linear discriminant analysis (LDA) and principal component analysis (PCA), and seven ML algorithms, for example, k-nearest neighbors (KNN), support vector machine, decision trees, naïve bayes, random forest (RF), gradient boosting, and extreme gradient boosting, were evaluated using a high-dimensional spectroscopic dataset containing measured nitrate-nitrite mixed solution absorbance data. Despite the limited and uneven number of samples per class, this study demonstrated that PCA outperformed LDA on the high-dimensional spectroscopic dataset. The classification accuracy of ML algorithms combined with PCA ranged from 92.7% to 99.8%, whereas the classification accuracy of ML algorithms combined with LDA ranged from 80.7% to 87.6%. The PCA with the RF algorithm exhibited the best performance with 99.8% accuracy.

Machine learning (ML) algorithms have been widely used in big data prediction and analysis in terms of their excellent data regression ability. However, the prediction accuracy of different ML algorithms varies between different regression problems and data sets. In order to construct a prediction model with optimal accuracy for fly ash concrete (FAC), ML algorithms such as genetic programming (GP), support vector regression (SVR), random forest (RF), extremely gradient boost (XGBoost), backpropagation artificial neural network (BP-ANN) and adaptive network-based fuzzy inference system (ANFIS) were selected as regression and prediction algorithms in this study; the particle swarm optimization (PSO) algorithm was also used to optimize the structure and hyperparameters of each algorithm. The statistical results show that the performance of the assembled algorithms is better than that of an NN-based algorithm. In addition, PSO can effectively improve the prediction accuracy of the ML algorithms. The comprehensive performance of each model is analyzed using a Taylor diagram, and the PSO-XGBoost model has the best comprehensive performance, with R2 and MSE equal to 0.9072 and 11.4546, respectively.

Application of machine and deep learning algorithms in optical microscopic detection of Plasmodium: A malaria diagnostic tool for the future

With the growing availability of remote sensing orbital spatial data, the applications of machine learning (ML) algorithms have been leveraging the field of process automation in image classification. The present work aimed to evaluate the precision and accuracy of ML algorithms in the classification of Sentinel 2A/2B images from an area of high environmental dynamics, such as Ria Formosa (Algarve, Portugal). The images were submitted to classification by groups of ML algorithms such as the Support Vector Machine (SVM), Random Forest (RF), K-Nearest Neighbors (KNN), and Decision Tree (DT). The Orfeo Toolbox (OTB) open-source programming package made the algorithms available. Ten samples were collected for each of the 14 land use and cover classes in the Ria Formosa area, totaling 140 samples. Of these, 70% were for training and 30% for validating the classification. The evaluation metrics used were the class discrimination measures: Recall (R), the Global Kappa Index (k), and the General Accuracy Index (OA). The results showed that the KNN and DT algorithms demonstrated a greater discrimination capacity for most classes. SVM and RF significantly improved class discrimination when using larger samples for training. Merging the classified images significantly improved the classification accuracy, ranging from 71% to 81%. This evaluation made it possible to define sets of ML algorithms sensitive to change detection for mapping and monitoring dynamic environments.

Artificial intelligence (AI) is the simulation of human intelligence in machines that are programmed to think and learn like humans. AI has the potential to revolutionise the way that healthcare professionals diagnose, treat, and manage conditions affecting the female reproductive system. Machine learning (ML) is a subset of AI which deals with the development of algorithms and statistical models that enable computers to learn from and make predictions or decisions without being explicitly programmed to do so. Deep learning (DL) is a subfield of ML that utilises neural networks with multiple layers, known as deep neural networks (DNNs), to learn from data. DNNs are inspired by the structure and function of the human brain and are capable of automatically learning high-level features from raw data, such as images, audio and text. DL has been very successful in various applications such as image and speech recognition, natural language processing and computer vision. ML algorithms can be divided into three categories: supervised learning, unsupervised learning, and reinforcement learning. Supervised learning algorithms are trained on a labelled dataset, where the desired output (label) is already known. Unsupervised learning algorithms are trained on an unlabelled dataset and are used to discover patterns or relationships in the data. Reinforcement learning algorithms are trained using a trial-and-error approach, where the agent receives a reward or penalty for its actions. The goal of reinforcement learning is to learn a policy that maximises the expected reward over time. AI and ML are increasingly being applied in the field of obstetrics and gynaecology, with the potential to improve diagnostic accuracy, patient outcomes, and efficiency of care. AI has been applied to the field of medicine for several decades. One of the earliest examples of AI in medicine was the development of MYCIN in the 1970s, a computer program that could diagnose bacterial infections and recommend appropriate antibiotic treatments. MYCIN was developed by a team at Stanford University led by Edward Shortliffe, and its success demonstrated the potential of AI in medical decision making. In the 1980s, AI-based expert systems such as DXplain, developed at Massachusetts General Hospital, were used to assist in the diagnosis of diseases. These early AI systems were based on rule-based systems and were limited in their capabilities. One of the earliest examples of AI was the development of computer-aided diagnostic systems for ultrasound images in the 1970s and 1980s. These systems were designed to assist radiologists in identifying fetal anomalies and other conditions. In recent years, there has been a renewed interest in the use of AI in obstetrics and gynaecology, driven by advances in ML and the availability of large amounts of data. One of the primary areas in which AI and ML are being used in obstetrics and gynaecology is in the analysis of imaging data, such as ultrasound and magnetic resonance imaging. AI algorithms can be trained to automatically identify and classify different structures in the images, such as the placenta or fetal organs, with high accuracy. Another area of focus is the use of AI to predict preterm birth. Researchers have used ML algorithms to analyse data from electronic health records and identify patterns that are associated with preterm birth. By analysing large datasets of patient information and outcomes, AI algorithms can identify patterns and risk factors that may not be apparent to human analysts. This can help to improve the prediction of obstetric outcomes and guide clinical decision making. In recent years, AI has also been applied in obstetrics and gynaecology for real-time monitoring of high-risk pregnancies and identifying fetal distress. These systems use ML algorithms to analyse data from fetal heart rate monitors and identify patterns that are associated with fetal distress. AI and ML are also being used to develop new tools for the management of gynaecological conditions, such as endometriosis and fibroids. These tools can be used to predict the progression of the disease and guide treatment decisions. One example of the use of AI in benign gynaecology is the development of computer-aided diagnostic systems for endometriosis. These systems use ML algorithms to analyse images of the pelvic region and identify the presence of endometrial tissue, which can be a sign of endometriosis. Another area where AI and ML are being applied is in the management of fibroids. ML algorithms are being used to analyse imaging data and predict the growth and behaviour of fibroids, which can aid in the development of personalised treatment plans. In the field of oncology, AI is being used to improve the accuracy and speed of cancer diagnosis. AI algorithms can analyse images of tissue samples to identify the presence of cancer cells and predict the likelihood of a positive outcome following treatment. AI algorithms can be trained to analyse images from pelvic scans and identify signs of ovarian cancer with high accuracy. In addition to these specific applications, AI and ML are also being used to improve the efficiency and organisation of care in obstetrics and gynaecology. For example, by analysing large amounts of clinical data, AI algorithms can be used to identify patients at high risk of complications, prioritise them for care and ensure that they receive the appropriate level of care in a timely manner. AI and ML have the potential to revolutionise the field of fertility and in vitro fertilisation (IVF). By using data from large patient populations, AI and ML algorithms can help identify patterns and predict outcomes that would be difficult for human experts to discern. This can lead to improvements in diagnosis, treatment planning, and overall success rates for patients undergoing IVF. One area where AI and ML are being applied is in the selection of embryos for transfer during IVF. By analysing images of embryos, AI and ML algorithms can predict which embryos are most likely to result in a successful pregnancy. Another area where AI and ML have shown potential is in the optimisation of culture conditions for embryos. This has the potential to improve the survival and development of embryos, leading to higher pregnancy rates. AI and ML are also being used to improve the timing of embryo transfer during IVF. By analysing data from patient medical histories, AI and ML algorithms can predict the optimal time for transfer to increase the chances of successful pregnancies. In addition to these applications, AI and ML are being used in other areas of fertility and IVF to improve patient outcomes. For example, AI and ML are being used to predict the likelihood of ovarian reserve, predict ovulation timing, and improve the efficiency and cost-effectiveness of fertility clinics. AI and ML are rapidly evolving fields that have the potential to revolutionise the field of surgery. These technologies can be used to assist surgeons in a variety of ways, from pre-operative planning to real-time guidance during procedures. One of the key areas where AI and ML are being applied in surgery is in image analysis. For example, algorithms can be used to automatically segment and identify structures in medical images, such as tumours or blood vessels. This can help surgeons plan procedures more accurately and reduce the risk of complications. Another area where AI and ML are being used in surgery is in the development of robotic systems. These systems can be programmed to perform specific tasks, such as suturing or cutting tissue, with a high degree of precision and accuracy. In addition, robotic systems can be equipped with sensors that provide real-time feedback to the surgeon, which can help to improve the outcome of the procedure. These systems can be programmed with advanced algorithms that allow them to make precise incisions, control bleeding, and minimise tissue damage. AI and ML can also be used to improve the efficiency and safety of surgical procedures. For example, algorithms can be trained to analyse data from vital signs monitors, such as heart rate and blood pressure, and alert surgeons to potential complications in real-time. AI and ML are also being used to assist with post-operative care. For example, algorithms can be used to analyse patient data and predict which patients are at risk of complications, such as infection or bleeding, allowing surgeons to take preventative measures. Overall, AI and ML have the potential to significantly improve the field of surgery by increasing accuracy and precision, reducing the risk of complications, and improving patient outcomes. As the technology continues to advance, it is likely that we will see an increasing number of AI-assisted surgical systems and applications in clinical practice. In gynaecology specifically, there is a scarcity of data and diversity in the data. This can lead to AI models that are not generalisable to certain populations or that make incorrect predictions for certain groups of patients. Overall, AI has the potential to improve the diagnosis and management of obstetrics and gynaecology conditions, and many studies have shown that AI systems can perform at least as well as human experts in several areas. However, it is important to note that AI and ML are still in the early stages of development in obstetrics and gynaecology and more research is needed to fully understand their potential benefits and limitations. Some of the key challenges facing the field include developing AI systems that can explain their decisions, improving the robustness of AI systems to adversarial attacks, and developing AI systems that can operate in a wide range of environments. However, it is important to note that AI is a complementary tool to the obstetrics and gynaecology specialist and it is not meant to replace human expertise. The preceding text is entirely a product of an AI system. The preceding review, Artificial Intelligence in Gynaecology: An Overview was composed and written by an evolutionary AI system, ChatGPT (Chat Generative Pre-trained Transformer). ChatGPT is an AI chatbot underpinned by the GPT architecture, an autoregressive language model that uses DL to produce human-like text. The system was trained on a dataset of over 500 GB of text data derived from books, articles, and websites prior to 2021. The system can engage in responsive dialogue, generate computer code, and produce coherent and fluent text.1 ChatGPT was conceived by OpenAI, an AI laboratory based in San Francisco, California, founded by Elon Musk and Sam Altman in 2015. Since its public release on November 30, 2022, the potential for use and misuse has exponentially grown,2 ultimately leading to the prohibition of the utilisation of AI systems by multiple organisations, including schools and universities. Prompted by this interest in AI, the aim of this study was to assess the capacity of ChatGPT to generate a scientific review. In January 2023, a multidisciplinary study group was assembled to develop the study protocol, confirm the methodology and approve the topic. This research was exempt from ethics review under National Health and Medical Research Council guidelines.3 ChatGPT was instructed to generate an narrative review based on dialogue with the lead author, AY. The input was informed by collaborative meetings of the study group over the study period. The study group nominated the topic, 'Artificial Intelligence in Gynaecology', but ChatGPT generated the title, structure and content for this paper. The study group defined the input parameters for ChatGPT and each AI output was reviewed by the authors for consistency and context, informing the next input. The dialogue thus became increasingly specific and refined in each iteration, as the initial general outline was expanded to include specific subheadings, academic language and academic references. The review was finalised from the ChatGPT output through an explicit composition protocol, limiting assembly to cut and paste, deletion to whole sentences (but not words) and conversion to Australian English. No grammatical or syntax correction was performed. The AI output was cross-referenced and verified by the study group. In this study, ChatGPT generated 7112 words in over 15 iterations, including 32 references. The output was restricted to the final review of 1809 words and nine unique references after removing duplicates4 and incorrect references (19). The final paper was submitted for blinded peer review. Thus, this study has demonstrated the capacity of an AI system, such as ChatGPT, to generate a scientific review through human academic instruction. AI is anticipated to expand the boundaries of evidence-based medicine through the potential of comprehensive analysis and summation of scientific publications. However, unlike systematic reviews or meta-analyses governed by explicit methodology, AI systems such as ChatGPT are the product of DL algorithms that are dependent upon the quality of the input to train the AI. Consequently, unlike systematic reviews, AI systems are bound by the bias, breadth, depth and quality of the training material. A dedicated medical AI would therefore be trained on an appropriate data set, such as the National Library of Medicine Medline/PubMed database. However, the volume of data is challenging: in 2022 alone, there were over 33 million citations equating to a dataset of almost 200 Gb for the minimum dataset. In contrast, ChatGPT has no external reference capabilities, such as access to the internet, search engines or any other sources of information outside of its own model. If forced outside of this framework, ChatGPT may generate plausible-sounding but incorrect or nonsensical responses.4 Most notably, pushing the AI to include references leads the system to generate bizarre fabrications.5 Our paper demonstrated that only 28% (9/32) of the references were authentic, although better than the 11% reported in a recent paper.6 In contrast to human writing, AI-generated content is more likely to be of limited depth, contain factual errors, fabricated references and repeat the instructions used to seed the output.7 The latter results in a formulaic language redundancy that all but identifies AI content. The human authors thus echo the conclusion of ChatGPT that AI is a complementary tool to the specialist and not meant to replace human expertise. For the moment. The authors report no conflicts of interest.

This study is designed to provide empirical evidence on the impact of machine learning algorithms on the Predictive Ability of Accounting Information, by investigating the predictive ability of machine learning algorithms as opposed to traditional prediction models that rely on accounting information, on the accuracy of stock price predictions. It also aims to investigate whether machine learning algorithms' predictive ability outperforms traditional prediction models' predictive ability in cash-holding prediction models. Additionally, this study seeks to explore the practical potential of integrating machine learning algorithms and accounting information into prediction models to improve the predictive ability of accounting information. To fulfill this study's expected objectives, the researcher used several approaches. Using a case study approach compared event study approach, the comparative analysis results revealed that accounting information's predictive ability was more accurate than the machine learning algorithms’ predictive ability in stock price predictions. This suggests that using machine learning algorithms does not necessarily result in better prediction performance and that machine learning algorithms are not the replacement for accounting information in financial predictions. using the empirical approach, 564 firm-year observations from 2019 to 2022 are analyzed to predict cash-holding. The researcher employed several algorithms such as decision trees, support vectors, and K-nearest neighbor, compared to multiple linear regression based on accounting information as prediction models. The empirical results showed that decision trees as complex algorithms were proven to yield higher accuracy. While, other prediction models, MLR, KN, and SV had (RMSE) and low R2, which indicates the Low accuracy of predictions. Also, the empirical results reported that accounting information significantly affects the accuracy of algorithms regarding cash-holding . Hence, the current study adds empirical evidence to related previous review through emphasizing the complementary nature between the roles of machine learning algorithms and accounting information in financial predictions. Machine learning algorithms must be considered a supporting tool to enhance the predictive ability of accounting information, not a replacement for it. At the same time, accounting information improves the accuracy of machine learning algorithms' predictions. Therefore, it has become necessary for accountants to master skills to maintain their jobs and assume new roles in the of artificial .This study is designed to provide empirical evidence on the impact of machine learning algorithms on the Predictive Ability of Accounting Information, by investigating the predictive ability of machine learning algorithms as opposed to traditional prediction models that rely on accounting information, on the accuracy of stock price predictions. It also aims to investigate whether machine learning algorithms' predictive ability outperforms traditional prediction models' predictive ability in cash-holding prediction models. Additionally, this study seeks to explore the practical potential of integrating machine learning algorithms and accounting information into prediction models to improve the predictive ability of accounting information. To fulfill this study's expected objectives, the researcher used several approaches. Using a case study approach compared event study approach, the comparative analysis results revealed that accounting information's predictive ability was more accurate than the machine learning algorithms’ predictive ability in stock price predictions. This suggests that using machine learning algorithms does not necessarily result in better prediction performance and that machine learning algorithms are not the replacement for accounting information in financial predictions. using the empirical approach, 564 firm-year observations from 2019 to 2022 are analyzed to predict cash-holding. The researcher employed several algorithms such as decision trees, support vectors, and K-nearest neighbor, compared to multiple linear regression based on accounting information as prediction models. The empirical results showed that decision trees as complex algorithms were proven to yield higher accuracy. While, other prediction models, MLR, KN, and SV had (RMSE) and low R2, which indicates the Low accuracy of predictions. Also, the empirical results reported that accounting information significantly affects the accuracy of algorithms regarding cash-holding . Hence, the current study adds empirical evidence to related previous review through emphasizing the complementary nature between the roles of machine learning algorithms and accounting information in financial predictions. Machine learning algorithms must be considered a supporting tool to enhance the predictive ability of accounting information, not a replacement for it. At the same time, accounting information improves the accuracy of machine learning algorithms' predictions. Therefore, it has become necessary for accountants to master skills to maintain their jobs and assume new roles in the of artificial .

BackgroundKidney disease progression rates vary among patients. Rapid and accurate prediction of kidney disease outcomes is crucial for disease management. In recent years, various prediction models using Machine Learning (ML) algorithms have been established in nephrology. However, their accuracy have been inconsistent. Therefore, we conducted a systematic review and meta-analysis to investigate the diagnostic accuracy of ML algorithms for kidney disease progression.MethodsWe searched PubMed, EMBASE, Cochrane Central Register of Controlled Trials, the Chinese Biomedicine Literature Database, Chinese National Knowledge Infrastructure, Wanfang Database, and the VIP Database for diagnostic studies on ML algorithms’ accuracy in predicting kidney disease prognosis, from the establishment of these databases until October 2020. Two investigators independently evaluate study quality by QUADAS-2 tool and extracted data from single ML algorithm for data synthesis using the bivariate model and the hierarchical summary receiver operating characteristic (HSROC) model.ResultsFifteen studies were left after screening, only 6 studies were eligible for data synthesis. The sample size of these 6 studies was 12,534, and the kidney disease types could be divided into chronic kidney disease (CKD) and Immunoglobulin A Nephropathy, with 5 articles using end-stage renal diseases occurrence as the primary outcome. The main results indicated that the area under curve (AUC) of the HSROC was 0.87 (0.84–0.90) and ML algorithm exhibited a strong specificity, 95% confidence interval and heterogeneity (I2) of (0.87, 0.84–0.90, [I2 99.0%]) and a weak sensitivity of (0.68, 0.58–0.77, [I2 99.7%]) in predicting kidney disease deterioration. And the the results of subgroup analysis indicated that ML algorithm’s AUC for predicting CKD prognosis was 0.82 (0.79–0.85), with the pool sensitivity of (0.64, 0.49–0.77, [I2 99.20%]) and pool specificity of (0.84, 0.74–0.91, [I2 99.84%]). The ML algorithm’s AUC for predicting IgA nephropathy prognosis was 0.78 (0.74–0.81), with the pool sensitivity of (0.74, 0.71–0.77, [I2 7.10%]) and pool specificity of (0.93, 0.91–0.95, [I2 83.92%]).ConclusionTaking advantage of big data, ML algorithm-based prediction models have high accuracy in predicting kidney disease progression, we recommend ML algorithms as an auxiliary tool for clinicians to determine proper treatment and disease management strategies.

Introduction/ Background Medical diagnoses have increasingly depended on digitized images obtained through cutting-edge technology. These algorithms offer a promising avenue to transform diagnostic processes in healthcare, with their application scope continually widening due to ongoing advancements. This paper explores machine learning's role in clinical analysis and prediction, examining various studies that apply these techniques in clinical diagnosis, focusing on their use in analyzing images and providing accurate diagnoses. Materials and Methods This study employs a comparative analysis approach, utilizing diverse machine learning algorithms like SVM, K-nearest neighbors, Random Forests, and Decision Trees to analyze digitized medical images and patient records. We extracted data from several medical databases, ensuring a varied and comprehensive dataset. We also evaluated the impact of different data characteristics on the algorithms' effectiveness, aiming to understand the variability in their diagnostic precision across various conditions. Results The results indicate that machine learning algorithms, particularly SVM, K-nearest neighbors, Random Forests, and Decision Trees, demonstrate significant accuracy in diagnosing diseases from digitized images and medical records. SVM and Random Forests showed particularly high effectiveness in clinical diagnosis, suggesting their robustness across different medical conditions and datasets. These findings underscore the potential of machine learning to enhance diagnostic precision and predict illnesses early, aligning with the growing trend of technology-driven medical diagnostics. Discussion The findings reinforce the pivotal role of machine learning in transforming medical diagnostics. The variability in algorithm performance highlights the necessity for tailored approaches, considering dataset specifics and the medical condition being diagnosed. This study underscores the potential of machine learning to enhance diagnostic accuracy, yet it also emphasizes the need for continuous refinement and understanding of the underlying factors affecting algorithm performance. Future research should focus on optimizing these algorithms within diverse clinical settings to fully harness their diagnostic capabilities. Conclusion This study highlights the transformative potential of machine learning in medical diagnostics, demonstrating how various algorithms can effectively analyze digitized images and patient records to diagnose diseases. While the performance of these algorithms varies based on dataset characteristics, the overall high accuracy underscores machine learning's promise in healthcare. As the field continues to evolve, machine learning is poised to become an integral part of clinical diagnosis, enhancing the accuracy and efficiency of medical evaluations and treatments.

In healthcare and medicine, deep learning and machine learning have emerged as essential techniques. These methods enable the analysis of massive amounts of data and the finding of patterns that can assist in disease diagnosis, prognosis, and therapy. Using machine learning algorithms, it is possible to construct prediction models that can aid healthcare practitioners in properly identifying who is at a higher risk of having a given condition. These models might potentially be used to detect disease-related early warning signs, which could help in early intervention and therapy. A excellent example of machine learning in healthcare is the creation of a user interface that allows people to enter their symptoms and assess if they are unwell. It can assist individuals in identifying potential health concerns and seeking proper medical assistance. Furthermore, this sort of application can give significant data that can be utilised in the future to increase the accuracy of machine learning algorithms. Popular web technologies such as React, CSS, and Flask may be leveraged to create user interfaces for machine learning applications. These technologies are typically used to construct interactive online applications, but they may also be utilised to create user-friendly interfaces for healthcare applications.

Performances of machine learning algorithms for individual thermal comfort prediction based on data from professional and practical settings

Big data phenotyping in rare diseases: some ethical issues

There has been no shortage of discussion about artificial intelligence and machine learning (ML) in the past decade. ML in healthcare is becoming more widely used and has potential impact on disease prevention and diagnosis. With growing interest in artificial intelligence and machine learning among biomedical engineering students, this work outlines the development of an introductory machine learning course for biomedical engineering (BME) graduate students. The course introduces high-level concepts behind ML algorithms and teaches students which ML algorithms are best suited to different kinds of biomedical-related problems. A paramount goal is to provide students an appreciation of knowing the "why" and not just the "how" in biomedical data analytics. In general, ML emphasizes the attainment of high accuracy in prediction. This is different in the biomedical field as a key part of the investigation is also to gain insight into or identify the important factors that can explain the underlying processes being studied. Students also learn the importance of pre-screening the data since "garbage in leads to garbage out", how to choose the most suitable ML algorithm for certain application and know the pitfalls of different methods. While this course is designed to provide BME students their first exposure to ML, it can also serve as the gateway to subsequent specialty ML courses, such as deep learning and probabilistic graphical models, or courses that utilize ML in specific application areas, such as computer vision and bioinformatics. The target group of this introductory course is primarily incoming graduate students and advanced undergraduates in BME or related disciplines including life science. The broad interdisciplinary background of BME students is the main factor that sets this course apart from machine learning courses traditionally taught in other engineering and computer science programs. A significant proportion of incoming BME Masters students intend to use our BME program as a bridge to switch or expand their base of expertise from biological sciences to engineering. Having a pool of students of non-homogeneous background is thus an additional major challenge in the development and delivery of this course. The class begins with the basics of probability, statistics, and programming. The rest of the semester covers various supervised and unsupervised learning algorithms with examples drawn from biomedical and life science applications. In addition, students are exposed to biomedical data such as measured physiological signals and medical images where features (certain characteristics of the signal or image) are extracted, and these features are then fed into the ML model. They also see typical issues with biomedical data such as imbalanced datasets in rare diseases or datasets with many missing values. Assessment in this course includes homework (conceptual and coding problems), a midterm exam (conceptual problems) and a group project. The project provides students with an opportunity to get hands-on experience of how one would approach a real-world biomedical problem. Students apply their machine learning knowledge and skills to tackle a biomedical related problem of choice. Assessment mapping, which maps questions on homework, exam and project to the course objectives, is used to evaluate students' ability in terms of dataset preparation, algorithm selection, algorithm implementation, interpretation of results and model evaluation. Having offered this course twice, we now have a better understanding of how diverse the student pool is in terms of their previous levels of preparation. Adjustments have been made particularly to coding exercises. Providing optional resources ranging from skeleton codes to short snippets to short hints allows students to choose the level of guidance they need. This work will discuss how the introduction to machine learning for biomedical engineers course was developed, what challenges were encountered and dealt with, and what improvements can be made going forward.

In recent years, the integration of artificial intelligence (AI) in healthcare has led to numerous groundbreaking applications that have transformed various aspects of medical practice. One of the primary areas where AI has made substantial contributions is in medical imaging analysis. By leveraging machine learning algorithms, AI systems can assist radiologists in interpreting medical images with greater accuracy and efficiency. AI-driven tools can detect subtle abnormalities, aid in early disease detection, and facilitate more precise diagnosis and treatment planning. Predictive analytics is another key application of AI in healthcare, wherein algorithms analyze vast amounts of patient data to forecast potential health outcomes and identify individuals at high risk of developing certain conditions. Additionally, the rise of virtual health assistants powered by AI has revolutionized patient care delivery by providing personalized and accessible healthcare services. These virtual assistants, often in the form of chatbots or voice-enabled interfaces, can interact with patients, answer medical queries, schedule appointments, and even provide medication reminders. Overall, the various applications of AI in healthcare, including medical imaging analysis, predictive analytics, personalized medicine, and virtual health assistants, have demonstrated significant potential in improving diagnostic accuracy, optimizing treatment plans, and enhancing patient care delivery. As these technologies continue to evolve and mature, they have the potential to revolutionize healthcare delivery and contribute to better health outcomes for individuals worldwide. This research paper contributes to the ongoing discourse surrounding the integration of AI in healthcare by providing a comprehensive overview of its advancements, challenges, and ethical considerations.